Priorities for the Treatment of Latent Tuberculosis Infection in the United States
about
Delineating a Retesting Zone Using Receiver Operating Characteristic Analysis on Serial QuantiFERON Tuberculosis Test Results in US Healthcare WorkersNovel human genetic variants associated with extrapulmonary tuberculosis: a pilot genome wide association studyPotential economic viability of two proposed rifapentine-based regimens for treatment of latent tuberculosis infectionDisease control implications of India's changing multi-drug resistant tuberculosis epidemicEarly versus Delayed Antiretroviral Therapy for HIV and Tuberculosis Co-Infected Patients: A Systematic Review and Meta-Analysis of Randomized Controlled TrialsOne-Year Tuberculosis Risk in Rheumatoid Arthritis Patients Starting Their First Tumor Necrosis Factor Inhibitor Therapy from 2008 to 2012 in Taiwan: A Nationwide Population-Based Cohort StudyMultiple cytokines are released when blood from patients with tuberculosis is stimulated with Mycobacterium tuberculosis antigensA Novel Tool Improves Existing Estimates of Recent Tuberculosis Transmission in Settings of Sparse Data CollectionHIV and Tuberculosis: a Deadly Human SyndemicOpportunistic infections in HIV disease.Detection of Mycobacterium tuberculosis from the stool of HIV sero-positive individuals suspected of pulmonary tuberculosisHeparin-binding-hemagglutinin-induced IFN-gamma release as a diagnostic tool for latent tuberculosis.A blood RNA signature for tuberculosis disease risk: a prospective cohort study.Evaluation of exposure-specific risks from two independent samples: a simulation studyImported infectious diseases in mobile populations, SpainTuberculosis infection in rural labor migrants in Shenzhen, China: Emerging challenge to tuberculosis control during urbanizationPriorities for screening and treatment of latent tuberculosis infection in the United StatesComparison of two interferon-gamma release assays (QuantiFERON-TB Gold In-Tube and T-SPOT.TB) in testing for latent tuberculosis infection among HIV-infected adults.Results of five-year systematic screening for latent tuberculosis infection in healthcare workers in PortugalRevisiting rates of reactivation tuberculosis: a population-based approachImproved sensitivity of an interferon-gamma release assay (T-SPOT.TB™) in combination with tuberculin skin test for the diagnosis of latent tuberculosis in the presence of HIV co-infectionMannose-capped lipoarabinomannan- and prostaglandin E2-dependent expansion of regulatory T cells in human Mycobacterium tuberculosis infectionCurrent approaches to tuberculosis in the United States.Recent advances in testing for latent TB.New approaches in the diagnosis and treatment of latent tuberculosis infectionDiabetes and immunity to tuberculosis.Impact of parenchymal tuberculosis sequelae on mediastinal lymph node staging in patients with lung cancer.Screening of imported infectious diseases among asymptomatic sub-Saharan African and Latin American immigrants: a public health challenge.Spatial dependency of tuberculosis incidence in TaiwanQuantiFERON-TB gold in-tube implementation for latent tuberculosis diagnosis in a public health clinic: a cost-effectiveness analysis.HIV infection disrupts the sympatric host-pathogen relationship in human tuberculosisLatent tuberculosis detection by interferon γ release assay during pregnancy predicts active tuberculosis and mortality in human immunodeficiency virus type 1-infected women and their childrenDescriptive review of the patients suffering from tuberculosis in the past 10 years treated at pediatric clinic of clinical center of sarajevo university.Latent tuberculosis in HIV positive, diagnosed by the M. tuberculosis specific interferon-gamma test.Novel developments in the epidemic of human immunodeficiency virus and tuberculosis coinfectionStrategy to better select HIV-infected individuals for latent TB treatment in BCG-vaccinated populationContribution of a heparin-binding haemagglutinin interferon-gamma release assay to the detection of Mycobacterium tuberculosis infection in HIV-infected patients: comparison with the tuberculin skin test and the QuantiFERON-TB Gold In-tubeLow yield of chest radiography in a large tuberculosis screening programTuberculosis: evidence review for newly arriving immigrants and refugees.Serial interferon-gamma release assays for the diagnosis of latent tuberculosis infection in patients treated with immunosuppressive agents.
P2860
Q21296671-19599687-29F2-4E5B-A528-C643891B2AA5Q24618920-9F19A341-B56D-4C2B-A956-FC7E252BA435Q28479103-0A1C5B29-6CA8-4E2E-826E-4760A56B7F71Q28540633-A71EEA42-BBCB-49FC-991D-DA57475082C5Q28547436-55DD3F51-8F85-4CED-9D8E-23A08E23ABBCQ28553438-D84F4CE8-AC8F-475F-B4C0-6E06F3EC0D30Q28742421-8A591BB1-7946-4C6E-81FD-2CFC59F4A0C6Q30000004-BE33BE10-0998-4692-944C-3CA38716B4D0Q30052157-3ECAA633-CDE8-409F-92EC-07D75E656A41Q30391927-BE7EB45E-E5F1-4AB6-A5FC-6E47AA50F071Q30402397-8E6C149D-437D-4573-8DB0-DB7D87D25377Q33301317-31A4D510-0203-4DAA-9FAA-C1BEEC1E4B15Q33566308-4E56E59A-14DE-42EF-8512-CF1301D9C0A4Q33786260-CF33A6D1-D959-4C0F-AFD9-4006D7184C0FQ33800686-E119E990-EEDC-44DA-A840-3578A004106CQ33860906-A155E6ED-BFAD-4FC3-93A6-58C5D5EBCE5FQ33895875-212CBBD0-607F-4A03-89F5-3924C085D90CQ33938067-D5DCF755-44C6-401B-90A5-896CF6289537Q34064827-1248F41D-DBE2-4FE4-9B20-52C85AAC849AQ34065641-A82F52FE-6806-4A1A-A62A-36788A5F87FAQ34075008-D655A3AE-2908-4848-B654-8C1B4DB72001Q34202238-03D4DBC7-46B2-4444-80C2-6BD5A1F90EE3Q34279727-B6B68187-7070-4CDA-B2F2-0F35AD80DB8CQ34386405-BA350854-66D9-47A2-B876-FB8553DC4205Q34419185-BBA9D8B1-B361-4314-B3C7-46BB7EC07C2DQ34424824-697C9D4E-0FEA-46F4-A578-B3360AB833A1Q34451922-5E2AC6E3-8266-4A32-9E2C-8106E092AF75Q34461033-5CA4A222-E2EF-47FD-AD5F-D9D6BDB2A177Q34505836-C72EFE57-2A75-4864-8701-89AEF543C1E7Q34518338-EC42AEFF-917C-4684-942F-21BFEA9CF034Q34625399-B47A04DB-0F19-4FE0-9295-FDFDDC7D55E5Q34678691-0327AFCA-D92B-4040-94A1-EC13C3C1D05FQ34725394-E93E1852-8BAD-4554-BF00-BF4659FDD0C5Q34872252-217ACB93-0277-4346-B4D2-B628D12BE45DQ34914625-A791699A-7434-49ED-A113-8943E98C7EB0Q34981656-AF1CBD2B-09D8-4422-AC33-387B54F63264Q35110105-F6C0AEF0-76F3-4C3B-A35C-824E06698455Q35144374-DB62C3A1-66F3-4382-81E4-11621630437EQ35201314-C4FB70D7-62F1-4E21-8651-F5DF0C613CF7Q35300301-2FE3EB3C-18F4-4663-AF63-A751EF069662
P2860
Priorities for the Treatment of Latent Tuberculosis Infection in the United States
description
article
@en
im Mai 2004 veröffentlichter wissenschaftlicher Artikel
@de
wetenschappelijk artikel
@nl
наукова стаття, опублікована в травні 2004
@uk
name
Priorities for the Treatment of Latent Tuberculosis Infection in the United States
@en
Priorities for the Treatment of Latent Tuberculosis Infection in the United States
@nl
type
label
Priorities for the Treatment of Latent Tuberculosis Infection in the United States
@en
Priorities for the Treatment of Latent Tuberculosis Infection in the United States
@nl
prefLabel
Priorities for the Treatment of Latent Tuberculosis Infection in the United States
@en
Priorities for the Treatment of Latent Tuberculosis Infection in the United States
@nl
P356
P1476
Priorities for the treatment of latent tuberculosis infection in the United States
@en
P2093
C. Robert Horsburgh
P304
P356
10.1056/NEJMSA031667
P407
P50
P577
2004-05-01T00:00:00Z